Literature DB >> 8379924

Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.

C H Williams1, T Yamamoto, D M Walsh, D Allsop.   

Abstract

It was reported recently that N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide (CPP-A-A-F-pAB), an inhibitor of endopeptidase 3.4.24.15 (E-24.15), also inhibits angiotensin-converting enzyme (ACE) from rabbit lung. We have found that this compound is without effect on ACE purified from pig kidney, at a concentration some 1000-fold greater than the Ki reported for inhibition of the enzyme from lung. However, preincubation of CPP-A-A-F-pAB with neutral endopeptidase 3.4.24.11 (E-24.11) does result in potent inhibitory effects on ACE. We have shown this to be due to formation of a fragment, CPP-A-A, the structure of which is closely related to ACE inhibitors such as enalaprilat. CPP-A-A was found to be a potent inhibitor of pig ACE. Under the conditions used it had an IC50 value of 1.6 x 10(-8) M, compared with the value obtained for captopril of 7.5 x 10(-10) M. These results have important implications for studies of E-24.15 when using CPP-A-A-F-pAB in vivo or in crude tissue extracts where E-24.11 might also be present.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379924      PMCID: PMC1134516          DOI: 10.1042/bj2940681

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15.

Authors:  A Pierotti; K W Dong; M J Glucksman; M Orlowski; J L Roberts
Journal:  Biochemistry       Date:  1990-11-13       Impact factor: 3.162

2.  Endopeptidase 24.15 from rat testes. Isolation of the enzyme and its specificity toward synthetic and natural peptides, including enkephalin-containing peptides.

Authors:  M Orlowski; S Reznik; J Ayala; A R Pierotti
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

3.  Thiol-dependent metallo-endopeptidase characteristics of Pz-peptidase in rat and rabbit.

Authors:  U Tisljar; A J Barrett
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats.

Authors:  E M Genden; C J Molineaux
Journal:  Hypertension       Date:  1991-09       Impact factor: 10.190

5.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

Authors:  P E Millican; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

6.  Inactivation of neurotensin by rat brain synaptic membranes partly occurs through cleavage at the Arg8-Arg9 peptide bond by a metalloendopeptidase.

Authors:  F Checler; J P Vincent; P Kitabgi
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

7.  Substrate-related potent inhibitors of brain metalloendopeptidase.

Authors:  M Orlowski; C Michaud; C J Molineaux
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

8.  Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum.

Authors:  H Barelli; J P Vincent; F Checler
Journal:  Eur J Biochem       Date:  1988-08-15

Review 9.  The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.

Authors:  A A Patchett; E H Cordes
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1985

10.  Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.

Authors:  G R Acker; C Molineaux; M Orlowski
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

View more
  4 in total

1.  Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.

Authors:  C N Shrimpton; G Abbenante; R A Lew; I Smith
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.

Authors:  F Tomoda; R A Lew; A I Smith; A C Madden; R G Evans
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.

Authors:  R A Lew; F Tomoda; R G Evans; L Lakat; J H Boublik; L A Pipolo; A I Smith
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.

Authors:  S E Telford; A I Smith; R A Lew; R B Perich; A C Madden; R G Evans
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.